What is HBOT?Hyperbaric Oxygen Therapy (HBOT) is a specialized oxygen treatment where up to 9 times the amount of oxygen is gently and safely pressured into the body to create hyperoxia - a raised dosing of oxygen that enhances the body’s natural healing processes in many ways. This done by being in a pressurised total body chamber where atmospheric pressure is increased and further oxygenation is increased by inhalation of 70% - 95% oxygen.
HBOT treats a wide range of medical conditions, depending on patient needs and the severity of the condition. There are 2 main types of HBOT:
- Mild HBOT is specialized oxygen treatment that enhances the body’s natural healing processes by inhalation of 70% - 95%% oxygen from an oxygen concentrator through an oxygen mask in a monoplace body chamber with increased atmospheric pressure levels between 1,3 ATA and 1,5 ATA. In several studies, it was found that pressures of 1,3 ATA with supplemental oxygen are proven to have the greatest increase in oxygen saturation percentages. Higher levels of oxygenation can be reached with oxygen masks either rebreather or non-rebreather depending on recommendation. mHBOT can be experienced through trained professionals at specific sites without requiring a doctor or specialized hospital clearance. OXYIVE MHBOT uses the Revitalair 430 Chamber from Biobarica, Argentina which operates effectively and efficiently at 1,49 ATA. The chamber is supplied and serviced by OXYGENATE Pty Ltd, South Africa, and used within the international safely protocols as required.
- Full HBOT is specialized oxygen treatment that enhances the body’s natural healing processes by inhalation of 100% oxygen via an oxygen mask in a total body chamber normally at atmospheric pressure levels between 1,5 ATA and 3 ATA. Pressures of 1,8 ATA and upward exert quite a pressure on the body affecting the ear drum and eyesight while under treatment. These affects are temporary and usually return to normal sometime after the session. These treatments require specialised treatment, a doctor and normally happens in a hospital or a clinic specialized for HBOT.
- In current related research studies, treatment parameters include a placebo setting which is typically set at 1.3 ATA, and a treatment group that typically receives 2.0 ATA. The outcome of many of these studies conclude that the benefits obtained from HBOT were the same regardless of the placebo setting or the treatment group setting. To reach oxygen saturation levels nearest 100% it can be concluded that a 1.3 ATA with supplemental oxygen treatment can prove to have the greatest increases in oxygen saturation percentages.